Results 11 to 20 of about 24,950 (282)
Anais Brasileiros de Dermatologia, 2020 Finasteride is a 5α-reductase enzyme inhibitor that has been approved for the treatment of male androgenic alopecia since 1997. Over time, it has been considered a safe and well-tolerated drug with rare and reversible side effects. Recently there have been reports of adverse drug-related reactions that persisted for at least three months after ...
Ana Francisca Junqueira Ribeiro Pereira +1 more
openaire +6 more sources
BMC Chemistry, 2022 Entadfi™ is a recently FDA approved pharmaceutical combination capsule of finasteride and tadalafil. It was prescribed for the treatment of urinary tract disorders caused by benign prostatic hyperplasia in men.
Ahmed H. Abdelazim, Sherif Ramzy
doaj +2 more sources
Finasteride and Its Potential for the Treatment of Female Pattern Hair Loss: Evidence to Date
Drug Design, Development and Therapy, 2020 Wimolsiri Iamsumang, Kanchana Leerunyakul, Poonkiat Suchonwanit Division of Dermatology, Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, ThailandCorrespondence: Poonkiat Suchonwanit Email poonkiat@hotmail ...
Iamsumang W +2 more
doaj +2 more sources
Finasteride interferes with prostaglandin-induced CatSper signalling in human sperm
Reproduction, 2021 Ca2+ signalling controls human sperm functions necessary for successful fertilization. Multiple endocrine-disrupting chemicals have been found to activate the CatSper Ca2+ channel and thereby interfering with Ca2+ signalling in human sperm.
Rehfeld, Anders +3 more
core +2 more sources
Skin Appendage DisordersIntroduction: Oral finasteride and topical minoxidil are longstanding androgenetic alopecia (AGA) treatments; topical finasteride is a more recent medicine. Few studies have compared their therapeutic effects in postmenopausal women.
Bamimore M. A. +5 more
core +2 more sources
Psychoneuroendocrinology, 2019 Persistent alteration of plasma neuroactive steroid levels associated with major depression has been recently reported in men after the suspension of the treatment for androgenetic alopecia with finasteride, an inhibitor of the enzyme 5alpha-reductase ...
S. Giatti +15 more
core +2 more sources
Altered Skin Permeation of Finasteride Using Clove Oil, Urea, and Lyophilized Powder of Grape Seed Extract [PDF]
Advanced Pharmaceutical Bulletin, 2023 Purpose: Finasteride is a 5-alpha reductase inhibitor used to treat hair loss and acne. The skin permeation of finasteride is one of the main challenges associated with dermal drug delivery.
Anayatollah Salimi +2 more
doaj +1 more source
Alteration of Gut Microbes in Benign Prostatic Hyperplasia Model and Finasteride Treatment Model
International Journal of Molecular Sciences, 2023 Gut microbes are closely associated with disease onset and improvement. However, the effects of gut microbes on the occurrence, prevention, and treatment of benign prostatic hyperplasia (BPH) are still unclear.
J. An +4 more
semanticscholar +1 more source
European Urology Open Science, 2023 Finasteride competitively inhibits 5α-reductase (5-AR) isoenzymes, which blocks dihydrotestosterone (DHT) production, thereby reducing DHT. Finasteride is used in the management of benign prostatic hyperplasia (BPH) and androgenic alopecia.
H. Al Saffar +5 more
semanticscholar +1 more source
Scientific Reports, 2023 Finasteride, a 5α-reductase inhibitor used in benign prostatic hyperplasia and androgenetic alopecia, has been associated with an increased suicidal risk, whereas it is unclear whether such risk is similar to that for another 5α-reductase inhibitor ...
M. Laanani +4 more
semanticscholar +1 more source